Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Jun 1;27(6):pyae022.
doi: 10.1093/ijnp/pyae022.

Subanesthetic Ketamine Suppresses Locus Coeruleus-Mediated Alertness Effects: A 7T fMRI Study

Thomas Liebe  1   2 , Lena Vera Danyeli  1   3   4   5 , Zümrüt Duygu Sen  1   3   4 , Meng Li  1   3   4 , Jörn Kaufmann  1   6 , Martin Walter  1   3   4   5
Affiliations
Randomized Controlled Trial

Subanesthetic Ketamine Suppresses Locus Coeruleus-Mediated Alertness Effects: A 7T fMRI Study

Thomas Liebe et al. Int J Neuropsychopharmacol. .

Abstract

Background: The NMDA antagonist S-ketamine is gaining increasing use as a rapid-acting antidepressant, although its exact mechanisms of action are still unknown. In this study, we investigated ketamine in respect to its properties toward central noradrenergic mechanisms and how they influence alertness behavior.

Methods: We investigated the influence of S-ketamine on the locus coeruleus (LC) brain network in a placebo-controlled, cross-over, 7T functional, pharmacological MRI study in 35 healthy male participants (25.1 ± 4.2 years) in conjunction with the attention network task to measure LC-related alertness behavioral changes.

Results: We could show that acute disruption of the LC alertness network to the thalamus by ketamine is related to a behavioral alertness reduction.

Conclusion: The results shed new light on the neural correlates of ketamine beyond the glutamatergic system and underpin a new concept of how it may unfold its antidepressant effects.

Keywords: Ketamine; LC functional connectivity; alertness; locus coeruleus; ultra-high field MRI.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The LC functional connectivity mixed design ANOVA comparing sessions (ketamine (blue boxplots), placebo (red boxplots) and time (baseline, administration) reveals changes to bilateral thalamus (left thalamus cluster size = 279, FDR P < .001; right thalamus cluster size = 163, FDR P < .001); a, b), brainstem regions (cluster size = 122, FDR P < .001; c) and cerebellum (d, cluster size = 279, FDR P < .001).
Figure 2.
Figure 2.
LC functional connectivity paired t test reveals decoupling of the LC to the bilateral thalamus, brainstem regions and cerebellum during the ketamine administration condition compared with the corresponding baseline session (left thalamus cluster size = 260, FDR P < .001; right thalamus cluster size = 84, FDR P < .001; cerebellum (cluster size = 305, P < .001); brainstem regions (cluster size = 134, P < .001).
Figure 3.
Figure 3.
(a) A paired t test reveals a significant decrease of ALFF within the left thalamus (cluster size = 55, FDR P < .001) in the ketamine infusion condition compared with the placebo infusion. (b) The extracted beta weights from the significant decreased LC fc to the left thalamus are correlated to the ALFF decrease of the left thalamic cluster (mixed design ANOVA; Pearson correlation P = .014), with lower LC-thalamic connectivity (measured by fc) relating to lower thalamic activity (measured by ALFF).
Figure 4.
Figure 4.
(a) In the attention network task we found a significantly diminished alerting effect in the ketamine condition compared with the placebo condition (P = .04, F = 63.003, mean difference: −10.817s). Neither orienting nor executive control showed any significant effects. (b) Whole brain LC functional connectivity ANCOVA shows correlations of alertness in the placebo administration condition within the bilateral thalamus (left thalamus cluster size = 134, FDR P<.001; right thalamus cluster size = 60, FDR P = .009).
See this image and copyright information in PMC

References

    1. Abram SV, Roach BJ, Fryer SL, Calhoun VD, Preda A, van Erp TG, Bustillo JR, Lim KO, Loewy RL, Stuart BK, Krystal JH, Ford JM, Mathalon DH (2022) Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia. Mol Psychiatry 27:2448–2456. - PMC - PubMed
    1. American Psychiatric Association (2005) Diagnostic and statistical manual of mental disorders (rev.). Arlington; APA.
    1. Aston-Jones G (2005) Brain structures and receptors involved in alertness. Sleep Med 6:S3–S7. - PubMed
    1. Aston-Jones G, Cohen J (2005a) Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493:99–110. - PubMed
    1. Aston-Jones G, Cohen JD (2005b) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28:403–450. - PubMed

Publication types

MeSH terms